Cell Investigation

Open access

ISSN: 3050-5380

Cell Investigation

Open access

Editor-in-Chief

Jian Yang
Guido Marcucci
Wei Mo

Editorial Board

Cell Investigation strives to publish original research findings that are of great significance or broad conceptual or technical advances in all areas of life sciences such as molecular and cell biolo...

Cell Investigation strives to publish original research findings that are of great significance or broad conceptual or technical advances in all areas of life sciences such as molecular and cell biology etc. The journal has an international authorship and a broad scope including basic experimental and translational research and clinical trial. The journal aims to providing a premier platform for disseminating cutting-edge research in the rapidly evolving field of normal and tumoral biology.

We seek studies that present advanced conceptions, methodologies, or technics that push the boundaries of scientific understanding in any areas of life sciences, including (but not limited to) the following topics:

  • Cell Homeostasis and Stress

  • Cell Metabolism

  • Cell Senescence and Aging

  • Cell Death

  • Cell Signalling

  • Cell Modulation and Manipulation

  • Cell-Based Drug Development, Screening, and Toxicology

  • Cell-Based Therapies and Translational Studies

  • Cancer Biology & Microbiome

  • Stem Cell and Cellular Differentiation

  • Neuroscience

  • Immunity

  • Molecular & Cell Biology

  • Molecular Genetics & Epigenetics

  • Omics & Systems Biology

  • Bionanotechnology

  • Artificial Intelligence in Health Care

The journal welcomes original research articles, letters, reviews, short communications, comments, and methodological papers that contribute to the advancement of knowledge in these areas. By providing a focused and inclusive platform, the journal aims to catalyze progress in life sciences.

Editorial Board

Advances in cancer treatment: The role of new technologies and research

RNA-binding protein Roq modulates the Drosophila STING antiviral immune response

Increased co-expression of CTLA4/LAG3 predicted adverse clinical outcomes in patients with T-cell malignancies

View all ScienceDirect

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.